Yerlikaya Aslihan, Bulbul Mustafa C, Afsar Baris, Dagel Tuncay, Aslan Gamze, Voroneanu Luminita, Siriopol Dimitire, Covic Adrian, Kanbay Mehmet
School of Medicine, Koç University, Istanbul, Turkey.
Division of Nephrology, Department of Medicine, Suleyman Demirel University School of Medicine, Isparta, Turkey.
Int Urol Nephrol. 2018 Mar;50(3):481-493. doi: 10.1007/s11255-017-1708-6. Epub 2017 Sep 22.
There is evidence that serum iron levels, regardless of the presence of anemia, directly impact outcomes in congestive heart failure (CHF) including quality of life, hospitalization rate and overall survival. Despite modern medical treatments, the prognosis of CHF remains grim. Ironically, simple iron replenishment may serve as a powerful tool in the armamentarium. This review will start from fundamental concepts of iron in oxygen delivery and analyze evidence-based outcomes in CHF iron-directed therapeutic trials. Imaging rationale that dovetails with this pathophysiology will also be detailed in a clinician-directed fashion.
有证据表明,无论是否存在贫血,血清铁水平都会直接影响充血性心力衰竭(CHF)的预后,包括生活质量、住院率和总生存率。尽管有现代医学治疗方法,但CHF的预后仍然严峻。具有讽刺意味的是,简单的铁补充可能是治疗手段中的有力工具。本综述将从铁在氧输送中的基本概念入手,分析CHF铁定向治疗试验中基于证据的结果。与这种病理生理学相契合的影像学原理也将以临床医生指导的方式详细阐述。